Methods and systems for dynamic variant thresholding in a liquid biopsy assay
AssigneeTempus Labs, Inc.
InventorsRobert Tell, Wei Zhu, Justin David Finkle, Christine Lo, Terri M. Driessen
Life of this patent
Estimating the term…
Loading patent…
AssigneeTempus Labs, Inc.
InventorsRobert Tell, Wei Zhu, Justin David Finkle, Christine Lo, Terri M. Driessen
Estimating the term…
Methods, systems, and software are provided for validating a somatic sequence variant in a subject having a cancer condition. Sequence reads are obtained from sequencing cell-free DNA fragments in a liquid biopsy sample of the subject. Sequence reads are aligned to a reference sequence. A variant allele fragment count and locus fragment count are identified for a candidate variant that maps to a locus in the reference sequence. The variant allele fragment count is compared against a dynamic variant count threshold for the locus. The threshold is based on a pre-test odds of a positive variant call for the locus, based on the prevalence of variants in a genomic region including the locus in a cohort of subjects having the cancer condition. The somatic sequence variant in the subject is validated, or rejected, when the variant allele fragment count for the candidate variant satisfies, or does not satisfy, the threshold.
A method of validating a somatic sequence variant in a cancerous tissue of a test subject having a cancer condition, the method comprising:
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.